Skip to main content
. 2022 Nov 21;12(51):33175–33179. doi: 10.1039/d2ra04958a

Cell viability of (±) 5.

Entry Name DU145 MV4-11 Jurkat PC3
1 (±) 5a 75.50 15.02 53.19 61.36
2 (±) 5b 62.58 37.09 33.85 25.48
3 (±) 5c 58.71 8.88 27.31 59.60
4 (±) 5d 54.40 10.02 30.11 54.07
5 (±) 5e 26.30 21.08 30.94 18.74
6 (±) 5f 100.78 17.28 43.14 66.43
7 (±) 5g 91.91 19.08 63.80 97.94
8 (±) 5h 74.02 15.76 37.18 78.48
9 (±) 5i 64.03 22.65 34.39 57.54
10 (±) 5j 93.17 18.92 40.33 93.37
11 (±) 5k 107.35 52.87 37.04 63.43
12 (±) 5l 68.02 17.05 47.33 67.17
13 (±) 5m 101.39 24.95 75.16 94.37
14 (±) 5o 101.35 11.96 43.29 76.40
15 (±) 5p 93.52 33.11 45.21 58.73
16 THZ1a 69.45 19.23 16.24 82.91
a

THZ1 is a selective inhibitor of CDK7.